好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2012 Annual Meeting | Research Coordinator Colloquium

Monday 04/23/12
03:00 PM - 06:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Colloquium
Petra Kaufmann, MD, FAAN
Participants should be familiar with regulatory issues specific to clinical trials in neurology, how to use social marketing strategies to improve recruitment and retention in clinical trials, and best practices in managing investigator-initiated and industry-sponsored clinical trials in neurological disorders and stroke.
No CME available
Interpersonal and Communication Skills, Professionalism, Medical Knowledge
Other, Trainee
Didactic, Interactive, Audience Participation

Program Evaluations

Event Timeline
03:00 PM - 03:15 PM Welcome and Introduction
Michael G. Benatar, MBChB, DPhil, FAAN, Petra Kaufmann, MD, FAAN
03:00 PM - 06:00 PM Break
03:15 PM - 03:45 PM Regulatory 101 in CNS Trials
Cornelia Kamp
03:45 PM - 03:50 PM Questions and Answers
03:50 PM - 04:20 PM Enhancing Recruitment and Retention in Neurology Trials with Social Marketing Strategies
Jamie N. Roberts
04:20 PM - 04:25 PM Questions and Answers
04:25 PM - 04:55 PM Investigator Initiated Trials in CNS Disorders
Karen Lane
04:55 PM - 05:00 PM Questions and Answers
05:00 PM - 05:30 PM Industry Sponsored Trials in CNS Disorders
Julaine M. Florence
05:30 PM - 05:35 PM Questions and Answers
05:35 PM - 06:00 PM Panel Discussion
Faculty Disclosures
Petra Kaufmann, MD, FAAN Dr. Kaufmann has received personal compensation for serving as an employee of Affinia Therapeutics. Dr. Kaufmann has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Kaufmann has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for DTx. Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Kaufmann has stock in Vigil Neuroscience. The institution of an immediate family member of Dr. Kaufmann has received research support from Cystic Fibrosis Foundation . Dr. Kaufmann has a non-compensated relationship as a Member of a Scientific Advisory Board with NIH that is relevant to AAN interests or activities.
Cornelia Kamp No disclosure on file
Michael G. Benatar, MBChB, DPhil, FAAN Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Jamie N. Roberts No disclosure on file
Julaine M. Florence Ms. Florence has nothing to disclose.
Karen Lane No disclosure on file